BackBone Biologics Overview

Bone Biologics Common Stock

Bone Biologics's common stock is $1.8K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$1795.00
↓ 45.11% YoYΔ $-1475.00 vs prior year quarter

Peer average / median

Loading

Bone Biologics Common Stock History

Loading

Bone Biologics vs. peers: Common Stock Comparison

Loading

Bone Biologics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Bone Biologics (BBLG) FAQ

As of the most recent data (March 2026), BBLG shows a common stock of $1.8K. That compares with $3.3K in the prior-year period — down 45.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBLG's common stock is now $1.8K (was $3.3K) — a 45.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bone Biologics is outperforming or lagging.

Tracking BBLG's common stock over time shows whether Bone Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8K That compares with $3.3K in the prior-year period — down 45.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Bone Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1.8K) with ownership activity and broader fundamentals.